Iti Pharma And Healthcare Fund Overview
Category Sectoral/ Thematic
BMSMONEY Rank N/A
BMSMONEY Rating N/A
Gro. Opt. As On: 19-11-2024
NAV ₹16.46(R) +0.79% ₹17.52(D) +0.8%
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) 43.4% 18.26% -% -% -%
LumpSum (D) 46.13% 20.73% -% -% -%
SIP (R) 17.45% 28.84% -% -% -%
SIP (D) 19.76% 31.38% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Top Sectoral/ Thematic
Fund Name Rank Rating
Franklin India Opportunities Fund 1
Icici Prudential India Opportunities Fund 2
Tata Business Cycle Fund 3
ICICI Prudential Business Cycle Fund 4

NAV Date: 19-11-2024

Scheme Name NAV Rupee Change Percent Change
ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option 16.46
0.1300
0.7900%
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 16.46
0.1300
0.7900%
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option 17.52
0.1400
0.8000%
ITI Pharma and Healthcare Fund - Direct Plan - IDCW Option 17.52
0.1400
0.8000%

Review Date: 19-11-2024

A review of the different performance parameters of the fund is as follows:
  1. Returns: It denotes the rise in the investment's worth during the investment period, expressed as a percentage or a monetary value. As part of our analysis, we evaluated five return parameters of this fund. We have classified the return parameters into three performance groups: the top 25%, parameters that fall below the top 25% but remain above average, and parameters that are below average. The performance of each parameter is outlined below.
    1. Top 25%: Four return parameters of the ITI Pharma and Healthcare Fund are in the top 25% in the category, as shown below:
      • 1M Return %
      • 3M Return %
      • 6M Return %
      • 1Y Return %
    2. Above Average Below the Top 25%: The ITI Pharma and Healthcare Fund has one return parameter in the category, which is above average but below the top 25%, as shown below:
      • 3Y Return %
    3. Below Average: ITI Pharma and Healthcare Fund has no return parameters that are below average in the category.
  2. Risk: It signifies the potential for financial loss or the failure to achieve anticipated returns due to diverse elements. We have analyzed zero risk parameters of ITI Pharma and Healthcare Fund, and divided it into three groups the lowest 25%, below average but above the lowest 25%, and above average. More details are provided below.
    1. Lowest 25%: ITI Pharma and Healthcare Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: ITI Pharma and Healthcare Fund does not have any risk parameters in the below average but above the lowest 25% of the category.
    3. Above Average: ITI Pharma and Healthcare Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: In mutual funds, risk-adjusted performance parameters are evaluation tools that gauge the returns of an investment against the risk taken. They assist investors in comparing various investments, factoring in both risk and returns. We have evaluated zero risk-adjusted performance parameters of the fund.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -2.23
-5.28
-8.31 | -1.24 2 | 30 Very Good
3M Return % 3.77
-4.30
-10.11 | 3.77 1 | 30 Very Good
6M Return % 20.82
4.94
-5.38 | 20.82 1 | 26 Very Good
1Y Return % 43.40
28.98
17.31 | 54.62 3 | 24 Very Good
3Y Return % 18.26
15.18
7.44 | 23.97 7 | 19 Good
1Y SIP Return % 17.45
-2.88
-13.00 | 17.45 1 | 24 Very Good
3Y SIP Return % 28.84
20.85
14.65 | 36.41 2 | 19 Very Good
Return data last Updated On : Nov. 19, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2024
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -2.09 -5.19 -8.16 | -1.15 2 | 30
3M Return % 4.25 -4.02 -9.82 | 4.25 1 | 30
6M Return % 21.94 5.54 -4.88 | 21.94 1 | 26
1Y Return % 46.13 30.45 17.68 | 56.50 3 | 24
3Y Return % 20.73 16.50 8.89 | 25.22 5 | 19
1Y SIP Return % 19.76 -1.70 -12.70 | 19.76 1 | 24
3Y SIP Return % 31.38 22.22 15.04 | 37.87 2 | 19
Return data last Updated On : Nov. 19, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2024
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D 0.79 ₹ 10,079.00 0.80 ₹ 10,080.00
1W -1.10 ₹ 9,890.00 -1.06 ₹ 9,894.00
1M -2.23 ₹ 9,777.00 -2.09 ₹ 9,791.00
3M 3.77 ₹ 10,377.00 4.25 ₹ 10,425.00
6M 20.82 ₹ 12,082.00 21.94 ₹ 12,194.00
1Y 43.40 ₹ 14,340.00 46.13 ₹ 14,613.00
3Y 18.26 ₹ 16,539.00 20.73 ₹ 17,597.00
5Y ₹ ₹
7Y ₹ ₹
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 17.45 ₹ 13,109.88 19.76 ₹ 13,253.39
3Y ₹ 36000 28.84 ₹ 54,529.09 31.38 ₹ 56,412.83
5Y ₹ 60000 ₹ ₹
7Y ₹ 84000 ₹ ₹
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Iti Pharma And Healthcare Fund NAV Regular Growth Iti Pharma And Healthcare Fund NAV Direct Growth
19-11-2024 16.4574 17.5221
18-11-2024 16.328 17.3834
14-11-2024 16.4666 17.5274
13-11-2024 16.3928 17.4479
12-11-2024 16.6403 17.7104
11-11-2024 16.7416 17.8174
08-11-2024 16.9353 18.0207
07-11-2024 16.9779 18.0651
06-11-2024 17.1272 18.223
05-11-2024 16.9669 18.0515
04-11-2024 16.909 17.9899
31-10-2024 16.9941 18.0767
30-10-2024 16.7534 17.8197
29-10-2024 16.7287 17.7925
28-10-2024 16.7549 17.8195
25-10-2024 16.5067 17.5528
24-10-2024 16.5742 17.6237
23-10-2024 16.3863 17.423
22-10-2024 16.4939 17.5365
21-10-2024 16.8335 17.8967

Fund Launch Date: 17/Nov/2021
Fund Category: Sectoral/ Thematic
Investment Objective: The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
Fund Description: An open ended equity scheme investing in Pharma and Healthcare
Fund Benchmark: Nifty Healthcare Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.